cardiac sarcoidosis
Information
- Disease name
- cardiac sarcoidosis
- Disease ID
- DOID:13405
- Description
- "A sarcoidosis that is characterized by conduction abnormalities, arrhythmias, and congestive heart failure with noncaseating granulomas present on endomyocardial biopsy, and develops_from a type IV hypersensitivity reaction with noncaseating granulomas infiltrating the myocardial tissue, especially that of the left ventricle." [url:https\://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731586/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT01764191 | Approved for marketing | 18F-FDG PET Imaging in Cardiac Sarcoidosis | |||
NCT03599414 | Completed | CASPA: CArdiac Sarcoidosis in PApworth | June 29, 2017 | March 8, 2023 | |
NCT03705884 | Completed | N/A | PET/MR Imaging In Patients With Cardiac Sarcoidosis | October 30, 2017 | December 1, 2018 |
NCT03746847 | Completed | PET Imaging in Patients With Suspected Cardiac Sarcoidosis | December 1, 2018 | December 1, 2022 | |
NCT03549598 | Completed | Phase 4 | d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis | July 20, 2018 | October 2, 2019 |
NCT01729169 | Completed | Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET | June 2012 | January 2015 | |
NCT04774549 | Enrolling by invitation | Inflammatory Cardiomyopathy Bern Registry | January 1, 2005 | December 31, 2026 | |
NCT05954507 | Not yet recruiting | N/A | Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis | May 1, 2024 | May 1, 2029 |
NCT05793398 | Not yet recruiting | Biomaterial Collection - and Analysis in Cardiac Sarcoidosis | April 1, 2023 | April 1, 2029 | |
NCT06409585 | Recruiting | Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition | May 1, 2023 | January 1, 2026 | |
NCT01477359 | Recruiting | Cardiac Sarcoidosis Multi-Center Prospective Cohort | August 2012 | December 2025 | |
NCT03049254 | Recruiting | Mayo AVC Registry and Biobank | February 9, 2018 | March 2025 | |
NCT03057002 | Recruiting | UTSW HP [13-C] Pyruvate Injection in HCM | May 1, 2018 | November 8, 2024 | |
NCT03593759 | Recruiting | Phase 3 | Cardiac Sarcoidosis Randomized Trial | January 15, 2019 | December 2025 |
NCT03902223 | Recruiting | N/A | Routine Cardiac Screening in Sarcoidosis Patients | April 5, 2019 | April 2029 |
NCT04737317 | Recruiting | Diagnostic Criteria in Cardiac Sarcoidosis | May 1, 2023 | January 1, 2027 | |
NCT04758650 | Recruiting | Phase 2 | Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis | January 26, 2021 | January 26, 2025 |
NCT05145023 | Recruiting | Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis | January 10, 2022 | May 31, 2025 | |
NCT05499637 | Recruiting | Phase 2 | [68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation | January 17, 2023 | January 2025 |
NCT06131112 | Recruiting | Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis | November 1, 2023 | January 2027 | |
NCT04017936 | Recruiting | Phase 2 | Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis | October 23, 2020 | September 2024 |
NCT04206163 | Recruiting | N/A | Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis | January 20, 2020 | December 2024 |
NCT03923049 | Terminated | N/A | Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis | May 21, 2019 | December 2, 2020 |
NCT03103490 | Terminated | Phase 2 | 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation | August 2, 2017 | September 28, 2021 |
NCT02017522 | Terminated | N/A | Non-Invasive Characterization in Cardiac Sarcoidosis | April 4, 2014 | July 7, 2015 |
NCT01210677 | Withdrawn | Phase 4 | Cardiac Sarcoidosis Response To Steroids Trial | April 2014 | December 2016 |
NCT02812849 | Withdrawn | Somatostatin Receptor Imaging in Cardiac Sarcoidosis | June 2016 | February 27, 2020 |
- Disase is a (Disease Ontology)
- DOID:11335
- Cross Reference ID (Disease Ontology)
- NCI:C35589
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:75403004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0392077